M5: Antibacterials Flashcards
Antibiotic:
Natural, e.g.
Synthetic, e.g.
Semi-synthetic, e.g.
a substance which kills bacteria or inhibits their growth
substance produced by organisms to kill/inhibit other organisms (aminoglycosides)
substances produced and discovered artificially (fluoroquinolones)
substances modified from those found naturally (beta-lactams)
Resistance to antibiotics threatens their success, speaking to the importance of:
Use antibiotics only _
Choose antibiotics _
Choose effective drugs with the _ once an organism has been identified (start _ -> de-escalate to _)
_ appropriately
Limit _ of therapy
when necessary (esp for viral infections)
appropriately
narrowest spectrum of activity
broad
narrow
Dose
durations
Points to Consider When Choosing an Antibiotic:
Identify the _ (or identify which _ to target empirically)
Match to _
_
_ / _
organism
organisms
antibiotic spectrum of activity
Sensitivity
Pharmacokinetics / Pharmacodynamics
Process of Starting Antibiotics (3)
empiric therapy
de-escalation
targeted therapy
Process of Starting Antibiotics:
Empirical Therapy
De-escalation
Targeted Therapy
choose antibiotics to cover a broad spectrum of possible organisms
culture & sensitivity data becomes available
choose antibiotics to cover a single pathogen
Antibiotic Classes:
Inhibitors of _ synthesis
Inhibitors of _ synthesis
Inhibitors of _ synthesis
_ damaging agents
_ damaging agents
cell wall
protein
DNA & RNA
DNA
cell membrane
Minimum Inhibitory Concentration (MIC):
Determines _
The (highest / lowest) concentration of antibiotic that results in _ (_)
Interpretation: _, _, or _
sensitivity
lowest
no visible growth (turbidity)
sensitive, intermediate, or resistant
Pharmacokinetics:
Definition
4 parts
the ways the body manipulates a drug
absorption
distribution
metabolism
excretion
Pharmacokinetics:
Absorption:
Bioavailability
Fluoroquinolones are (very / poorly) bioavailable
Vancomycin is (very / poorly) bioavailable
Level of drug in blood when given orally/given intraveneously X 100%
very
poorly
Pharmacokinetics:
Distribution:
Measured by _.
Good indicator is to assess concentrations in _ sites (_, _, _, _, etc.)
_ is an unique site, drug penetration depends on a number of factors including _, _, _, and _
Tobramycin: (good / poor) CNS distribution
Rifampin: (good / poor) CNS distribution
Volume of Distribution (L/kg)
sequestered
Cerebrospinal fluid, prostate, bone, abscess, etc.
Blood-brain barrier
molecular weight, lipophilicity, plasma protein binding, and active transport mechanisms
poor
good
Pharmacokinetics:
Metabolism:
Aminoglycosides: drugs that are (heavily / minimally) metabolized before being excreted unchanged
Moxifloxacin: drugs that are (heavily / minimally) metabolized
minimally
heavily
Pharmacokinetics:
Excretion:
_ vs. _ (e.g., biliary, feces, etc.)
_ eliminated drugs require dosage adjustment in renal failure (_) to avoid toxicity
_ eliminated drugs may not (_)
Renal vs. non-renal
Renally
penicillin
Non-renally
moxifloxacin
Pharmacodynamics:
Aspects (3)
the biochemical and physiologic effects of the drug and its mechanism of action (effects of the drug on the organism and body)
mechanism of action
toxicities
indices associated w/ optimal activity (concentration vs. time vs. exposure dependent)
Concentration-dependent killing:
The rate of cell killing increases with _
More effective: (400 mg once daily / 100mg four times daily)
Concentration dependent drugs (4)
each increase in peak concentration of antibiotic.
400 mg once daily
aminoglycosides
daptomycin
metronidazole
fluoroquinolones
Time-dependent killing:
The rate of cell killing increases with _
More effective: (400 mg once daily / 100mg four times daily)
Time Dependent drugs (3)
increasing amount of time that the concentration of antibiotic remains above a certain threshold (the MIC of the organism) for a majority of the dosing interval.
100mg four times daily
beta-lactams
linezolid
trimethoprim/sulfamethoxazole
Exposure Dependent killing:
Based
Exposure dependent drugs
neither entirely on peak concentration or time above MIC, rather based on total daily exposure
all other drugs (e.g. vancomycin)